Indoleamine 2,3-dioxygenase 1 expression predicts cholangiocarcinoma patient survival

Key Points

• The aim is to evaluate the prognostic significance of ido1 expression in cholangiocarcinoma patients.
• Analyzed ido1 expression levels in cholangiocarcinoma tissue samples.
• Correlated ido1 levels with patient survival metrics.
• Used statistical methods to assess the independence of ido1 as a prognostic factor.
• High ido1 expression was associated with significantly lower survival rates.
• ido1 expression was identified as an independent prognostic factor.
• Results suggest that ido1 could inform treatment planning for cholangiocarcinoma patients.